Switch to
More onapp

ANG Lifesciences India Ltd

ANG
Health CarePharmaceuticals
SmallcapWith a market cap of ₹195 cr, stock is ranked 1,789
High RiskStock is 3.55x as volatile as Nifty
151.951.25 (+0.83%)

Price Chart

High
Low
Returns
1D
1W
1M
1Y
5Y
Max
SIP
Loading...
1D
1W
1M
1Y
5Y
Max
SIP
Investment Checklist
BasicPro
Go pro! Unlock deeper insights
Health CarePharmaceuticals
SmallcapWith a market cap of ₹195 cr, stock is ranked 1,789
High RiskStock is 3.55x as volatile as Nifty

Key MetricsEdit

PE RatioPE Ratio
4.84
PB RatioPB Ratio
4.69
Dividend YieldDiv. Yield
Sector PESector PE
35.47
Sector PBSector PB
4.33
Sector Div YldSctr Div Yld
0.91%

Forecast & RatingsDetailed Forecast 

Forecast data is currently unavailable for this stock

Price

Price Upside

Earnings

Earnings Growth

Revenue

Rev. Growth

See Detailed Forecast

Company Profile

ANG Lifesciences India is a pharmaceutical company, engaged in the business of manufacturing and marketing of finished pharmaceutical formulations in a dosage form of sterile dry powder injection vials

Investor PresentationView older 

Aug 14, 2022

PDF
View Older Presentations

Financial TrendFinancial statements 

2019202020212022121.93127.25154.94355.205.666.097.0340.30
Revenue
Profit
All values in ₹ cr.
See financial statements

Holdings TrendDetailed holdings 

Total Promoter Holding
Increasing promoter holding is considered good and reflects management’s positive view about the future outlook

In last 6 months, promoter holding in the company has almost stayed constant

High Pledged Promoter Holding
Lower pledged promoter holdings is considered better

A significant proportion of promoter holdings is pledged

Mutual Fund Holding
Increasing Mutual Fund holdings are generally considered good, as it reflects that fund managers are becoming more bullish about the stock

In last 3 months, mutual fund holding of the company has almost stayed constant

See detailed holdings

Recent NewsAll news 

Hmm, looks like data is unavailable here. Please come back after some time
See all news

Recent EventsAll events 

Investor Presentation 
Announced OnAug 14, 2022

ANG Lifesciences India Ltd - 540694 - Announcement under Regulation 30 (LODR)-Investor Presentation | Download

ANG Lifesciences India Ltd - 540694 - Announcement under Regulation 30 (LODR)-Investor Presentation | Download

Cash Dividend 
Ex. DateNov 2, 2021

Interim • Div/Share: ₹ 1

See all events